<?xml version="1.0" encoding="UTF-8"?>
<ref id="B25-molecules-26-00431">
 <label>25.</label>
 <element-citation publication-type="book">
  <person-group person-group-type="author">
   <name>
    <surname>Wezeman</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Masters</surname>
    <given-names>K.-S.</given-names>
   </name>
  </person-group>
  <article-title>Chapter 12 Xanthones are Privileged Scaffolds in Medicinal Chemistryâ€”But are they Over-privileged?</article-title>
  <source>Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation</source>
  <publisher-name>The Royal Society of Chemistry</publisher-name>
  <publisher-loc>London, UK</publisher-loc>
  <year>2016</year>
  <fpage>312</fpage>
  <lpage>347</lpage>
  <pub-id pub-id-type="doi">10.1039/9781782622246-00312</pub-id>
 </element-citation>
</ref>
